Abstract:Objective: Cardiac resistance to IGF-I occurs in diabetes and is attributed to cardiac dysfunction in diabetes. However, the mechanism of action responsible for cardiac lGF-I resistance is Still unknown. This study was designed to examine the impact of high glucose on lGF-1-induced contractile response and activation of serine-threonine kinase Akt as well as extracellular signal-regulated kinase (ERK1/2) in cardiac myocytes. Methods: Isolated adult rat vermicular myocytes were Cultured for 12-18 h in a serum-free medium containing either normal (NG. 5.5 mM) or high (HG, 25.5 HIM) glucose. Mechanical properties were evaluated using an lonOptix MyoCam(R) system. Myocytes were electrically stimulated at 0.5 Hz and contractile properties analyzed included peak shortening (PS), time-to-PS (TPS) and time-to-90% relengthening (TR90). Intracellular Ca2+-induced Ca2+ release was measured as fura-2 fluorescence intensity change (DeltaFFI). Protein levels of total and phosphorylated Akt and ERK1/2, indicators of Akt and ERK1/2 activation, IGF- I receptors (pro-IGF-IR and IGF-IRalpha) as well as the glucose transporter GLUT4 were assessed by Western blot. Results: IGF-I (10(-10)-10(-6) M) elicited a close-dependent increase in PS and DeltaFF1 in myocytes maintained in NG medium. However, IGF-I induced a negative response on PS and DeltaFFI in HG myocytes. The lGF-1-induced responses in NG or HG myocytes were blunted by the IGF-I receptor antagonist H-1356. Western blot analysis revealed that IGF-1Ralpha but not pro-IGF-IR was reduced in HG myocytes. While IGF-I 10(-6) M) upregulated total Akt protein levels in both NG and HG myocytes, it only induced a significant activation of Akt in NG but not HG myocytes. IGF-I elicited comparable ERK1/2 activation in both NG and HG inyocytes. Conclusion: These results suggest that the cardiac IGF-I resistance in diabetes is likely attributed, at least in part. to reduced IGF-IR and attenuated IGF-I-induced Akt phosphorylation under elevated extracellular glucose. (C) 2003 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.

Activation of PI3Kγ/Akt Pathway Increases Cardiomyocyte HMGB1 Expression in Diabetic Environment

Activation Of Pi3k Gamma/Akt Pathway Increases Cardiomyocyte Hmgb1 Expression In Diabetic Environment

O-GlcNAcylation Involvement in High Glucose-Induced Cardiac Hypertrophy Via ERK1/2 and Cyclin D2

The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats

The signal transduction pathway of PKC/NF-kappa B/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats.

PPARγ–PI3K/AKT–NO Signal Pathway is Involved in Cardiomyocyte Hypertrophy Induced by High Glucose and Insulin

Hmgb1 Mediates Hyperglycaemia-Induced Cardiomyocyte Apoptosis Via Erk/Ets-1 Signalling Pathway

High Glucose Activates Prolyl Hydroxylases and Disrupts HIF-α Signaling via the P53/TIGAR Pathway in Cardiomyocyte

Inhibition of High-Mobility Group Box 1 Improves Myocardial Fibrosis and Dysfunction in Diabetic Cardiomyopathy

Abstract 11165: Activation of IGF-1/PI3/GSK-3ss Signaling Prevents High Glucose-induced Transition of Human Cardiac Progenitor Cells into Fibroblasts

Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway

Hyperglycemia Altered the Fate of Cardiac Stem Cells to Adipogenesis Through Inhibiting the Β-Catenin/tcf-4 Pathway

Hyperglycemia-Induced Protein Kinase C Β2 Activation Induces Diastolic Cardiac Dysfunction in Diabetic Rats by Impairing Caveolin-3 Expression and Akt/eNOS Signaling

High Glucose Induces Cardiac Insulin-Like Growth Factor I Resistance in Ventricular Myocytes: Role of Akt and ERK Activation

Hyperglycemia Induces Cardiomyocyte Hypertrophy In Part Through Pkc Beta 2 Activation In Cultured Neonatal Rat Myocytes

Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor Α.

High Levels of Glucose Induce Apoptosis in Cardiomyocyte Via Epigenetic Regulation of the Insulin-Like Growth Factor Receptor

Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway

Recombinant High‑mobility Group Box 1 Induces Cardiomyocyte Hypertrophy by Regulating the 14‑3‑3η, PI3K and Nuclear Factor of Activated T Cells Signaling Pathways.

High-mobility Group AT-hook 1 Promotes Cardiac Dysfunction in Diabetic Cardiomyopathy Via Autophagy Inhibition

1303-P: Decreased Hepatic HMGB1 in Type 2 Diabetes Increases Mitochondrial Glucose Uptake by Regulating Insulin/AKT Signaling